Cargando…
Intraoperative use of tranexamic acid to reduce blood loss during cytoreductive surgery for advanced ovarian cancer: A randomized controlled clinical trial
INTRODUCTION: Tranexamic acid reduces blood loss and allogeneic transfusion requirements in various surgical procedures. The role of tranexamic acid during cytoreductive procedures in advanced ovarian cancer is not clear. MATERIAL AND METHODS: This was a single center randomized, controlled, three‐a...
Autores principales: | Yang, Xijun, Chai, Mao, Xia, Lingfang, He, Zhiyong, Wu, Xiaohua, Zhang, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10333657/ https://www.ncbi.nlm.nih.gov/pubmed/37029431 http://dx.doi.org/10.1111/aogs.14567 |
Ejemplares similares
-
Effect Analysis of Preoperative Intravenous Tranexamic Acid Combined With Intraoperative Immersion in Reducing Perioperative Blood Loss of One Stage Posterior Thoracolumbar Tuberculosis
por: Zheng, Bowen, et al.
Publicado: (2022) -
Incidence of and survival after surgical intervention for bowel obstruction in women with advanced ovarian cancer
por: Pálsdóttir, Kolbrún, et al.
Publicado: (2023) -
Tranexamic acid in hip fracture patients: a protocol for a randomised, placebo controlled trial on the efficacy of tranexamic acid in reducing blood loss in hip fracture patients
por: Gausden, Elizabeth Bishop, et al.
Publicado: (2016) -
Cytoreduction (Peritonectomy Procedures) Combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Advanced Ovarian Cancer: Retrospective Italian Multicenter Observational Study of 511 Cases
por: Di Giorgio, Angelo, et al.
Publicado: (2016) -
High-Dose Tranexamic Acid in Patients Underwent Surgical Repair of Aortic Dissection Might Reduce Postoperative Blood Loss: A Cohort Analysis
por: Guo, Jingfei, et al.
Publicado: (2022)